Profile
James F.
Tanguay worked as VP-Chemistry, Manufacturing & Controls at Vion Pharmaceuticals, Inc. from 2007 to 2010 and as Vice President-Technical Operations at KOS Pharmaceuticals, Inc. from 1996 to 2007.
He completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and his doctorate degree at the University of Connecticut.
Former positions of James F. Tanguay
Companies | Position | End |
---|---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 2010-01-31 |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Chief Tech/Sci/R&D Officer | 2007-03-31 |
Training of James F. Tanguay
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
University of Connecticut | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- James F. Tanguay